These results suggest there is no excess cardiovascular risk with tirzepatide and are consistent with the improvements of numerous surrogate markers of cardiovascular health, including weight reduction, glycemic control with less hypoglycemia, blood pressure reduction, and improvements in the lipid profile
The relative effects of induced activation on each of the receptors are likely crucial for optimal efficacy, since for example overly strong activation of GLP1R tends to introduce adverse events (AEs) such as nausea
During your visit, your provider will discuss your personal goals, whether its weight management or improved blood sugar control
ipharmapharmacy.com 6PubMed (March 4, 2026)
How often should I get vitamin shots
Alcohol: Drinking excessive amounts of alcohol has also been linked with weight gain